Shionogi Inc. Announces FDA Approval Of CUVPOSA™ For The Treatment Of Chronic Severe Drooling In Pediatric Patients With Neurologic Conditions
Links shared publicly online about this topic.
- 985total visits
Shionogi Inc. Announces FDA Approval Of CUVPOSA™ For The Treatment Of Chronic Severe Drooling In Pediatric Patients With Neurologic Conditions
View full resource at medicalnewstoday.com
Tags: Neurology, Drug, Children's Health, FDA, Shionogi
Most Recently Shared on July 30, 2010 at 6:04 pm By:
Shionogi Inc. Announces FDA Approval Of CUVPOSA™ For The Treatment Of Chronic Severe Drooling In Pediatric Patie... http://mnt.to/3GLX
Also Shared By:
Shionogi launches CUVPOSA for pediatric chronic severe drooling
news-medical.net — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. commercial availability of CUVPOSA™ (glycopyrrolate) oral solution, the first and only FDA-approved treatment to reduce chronic severe drooling in patients aged 3 to 16 with neurologic conditions associated with problem drooling, such as cerebral palsy.” View full resource at news-medical.net
Most Recently Shared on April 7, 2011 at 2:09 pm By:
Shionogi launches CUVPOSA for pediatric chronic severe drooling: Shionogi Inc., the U.S.-based group company of ... http://bit.ly/gMBd6q
Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medication For The Treatment Of ADHD
medicalnewstoday.com — “Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., announced the U.S. Food and Drug Administration approval of the non-stimulant medication KAPVAY™ (clonidine hydrochloride” View full resource at medicalnewstoday.com
Most Recently Shared on October 6, 2010 at 3:05 pm By:
Shionogi Announces FDA Approval Of KAPVAY™ - The First And Only Therapy Approved For Use With Stimulant Medicati... http://mnt.to/3KPx
Advertisement





Neurology OW
@Neurology_OW
Shionogi Inc. Announces FDA Approval Of CUVPOSA For The Treatment Of Chronic Severe Drooling In Pediatric Patients... http://mnt.to/f/3GLX
1 year ago...